I am a board-certified molecular geneticist with a special interest in cancer genetics. As the director of the Diagnostic Molecular Genetics Laboratory at Memorial Sloan-Kettering, I am responsible for supervising the molecular diagnostic testing for inherited disorders — in particular the inherited forms of breast, ovarian, colorectal, and other types of cancers. The identification of genetic alterations enables better medical management options that can reduce risk through prevention or early detection. I have led the development and implementation of various new diagnostic genetic tests. I also oversee strategic planning for the laboratory's technologies, instrumentation, staffing, budget, and regulatory issues.
I am a member of the Clinical Testing Advisory Group (CTAG) at Memorial Sloan-Kettering. The role of CTAG is to evaluate the strength and quality of the clinical evidence supporting new assays and to determine whether the available evidence supports a uniform approach for providing these tests to our patients. With the availability of next-generation sequencing (NGS) technology, I am actively bringing in innovative, cutting-edge clinical molecular diagnostic tests to provide physicians with the information they need to better care for their patients.